STACI MURPHY: Open Payments
NPI 1235155722 · BLOOMINGTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$464 in 25 payments from 10 companies in 2025. Trend: 2023 $772 · 2024 $806 · 2025 $464
Food & beverage: $464
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $157 |
| Novartis Pharmaceuticals Corporation | 4 | $105 |
| Amgen Inc. | 2 | $41 |
| LEO Pharma Inc. | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 2 | $30 |
| UCB, Inc. | 1 | $21 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $19 |
| GENZYME CORPORATION | 1 | $19 |
| ABBVIE INC. | 1 | $18 |
| Biofrontera Inc. | 1 | $17 |
Products named: TREMFYA, COSENTYX, DUPIXENT, OTEZLA, Rhapsido, Bimzelx, ANZUPGO, ILUMYA.
Industry payments across IN — which companies pay providers there.
